Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:31 pm Sale |
2024-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 5,755,577 5.700% |
-2,054,275 (-26.30%) |
Filing History |
| 2025-02-12 09:28 am Purchase |
2024-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR LLC | 12,887,467 12.800% |
1,600,140 (+14.18%) |
Filing History |
| 2024-11-14 4:30 pm Sale |
2024-09-30 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
Atlas Venture Fund XI, L.P. | 4,869,681 5.500% |
-1,178,137 (-19.48%) |
Filing History |
| 2024-11-07 09:24 am Purchase |
2024-11-06 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR LLC | 11,287,327 11.192% |
3,874,947 (+52.28%) |
Filing History |
| 2024-11-07 09:12 am Purchase |
2024-11-06 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR LLC | 7,412,380 7.539% |
3,444,214 (+86.80%) |
Filing History |
| 2024-08-05 5:05 pm Unchanged |
2024-08-01 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
AI Day1 LLC | 12,929,322 13.150% |
0 (Unchanged) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 7,809,852 9.000% |
769,230 (+10.93%) |
Filing History |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
The Vanguard Group | 4,769,746 5.480% |
4,769,746 (New Position) |
Filing History |
| 2024-02-09 4:08 pm Purchase |
2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
Atlas Venture Fund XI, L.P. | 6,047,818 6.900% |
39,284 (+0.65%) |
Filing History |
| 2024-02-09 08:50 am Sale |
2024-02-08 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR LLC | 3,968,166 4.558% |
-2,050,892 (-34.07%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
BlackRock Inc. BLK |
5,126,071 5.900% |
5,126,071 (New Position) |
Filing History |
| 2023-10-20 4:01 pm Purchase |
2023-10-18 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
AI Day1 LLC | 12,929,322 14.870% |
1,475,454 (+12.88%) |
Filing History |
| 2023-08-10 08:19 am Sale |
2023-08-09 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR LLC | 6,019,058 6.931% |
-2,983,252 (-33.14%) |
Filing History |
| 2023-06-12 4:12 pm Purchase |
2023-06-09 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
AI Day1 LLC | 11,453,868 13.190% |
769,230 (+7.20%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 7,040,622 9.600% |
2,075,034 (+41.79%) |
Filing History |
| 2023-02-14 4:23 pm Sale |
2022-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
Atlas Venture Fund XI, L.P. | 6,008,534 8.200% |
-1,201,708 (-16.67%) |
Filing History |
| 2023-02-09 09:59 am Purchase |
2023-02-09 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
FMR LLC | 9,002,310 12.239% |
693,136 (+8.34%) |
Filing History |
| 2023-02-03 5:06 pm Sale |
2022-06-21 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% |
-6,012,758 (Position Closed) |
Filing History |
| 2022-11-02 4:15 pm Sale |
2022-10-31 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
Canaan XI L.P. | 2,548,403 3.500% |
-2,200,000 (-46.33%) |
Filing History |
| 2022-10-19 5:29 pm Sale |
2022-10-17 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
Canaan XI L.P. | 4,748,403 6.500% |
-2,215,898 (-31.82%) |
Filing History |